Press Releases Xenon Pharmaceuticals Inc.

Equities

XENE

CA98420N1050

Delayed Nasdaq Other stock markets 03:48:01 2024-04-30 pm EDT			5-day change	1st Jan Change
41.16 ^USD	-3.67%		+0.09%	-10.71%

Apr. 19	Xenon Pharmaceuticals Inc. Announces Board Resignations	CI
Mar. 11	Transcript : Xenon Pharmaceuticals Inc. Presents at Leerink Partners Global Biopharma Conference 2024, Mar-11-2024 11:20 AM

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting	Apr. 16	GL
Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	Apr. 10	GL
Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference	Apr. 04	GL
Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Days	Mar. 12	GL
Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Days	Mar. 12	AQ
Xenon Pharmaceuticals : Alberta Securities Commission British Columbia Securities Commission Ontario Securities Commission - Form 8-K	Mar. 08	PU
Xenon Pharmaceuticals to Present at Leerink Partners Global Biopharma Conference 2024	Mar. 05	GL
Xenon Pharmaceuticals to Present at Leerink Partners Global Biopharma Conference 2024	Mar. 05	AQ
Xenon Pharmaceuticals: Q4 Earnings Snapshot	Feb. 29	AQ
Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	Feb. 29	GL
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update	Feb. 22	AQ
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update	Feb. 22	GL
Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2024	Jan. 08	GL
Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2024	Jan. 08	AQ
Xenon Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference	Jan. 03	GL
Xenon Pharmaceuticals Announces Closing of $345.0 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares	Dec. 04	GL
Xenon Pharmaceuticals Provides Updates on Neurology Pipeline Programs at the Annual Meeting of the American Epilepsy Society (AES 2023)	Dec. 02	AQ
Xenon Pharmaceuticals Provides Updates on Neurology Pipeline Programs at the Annual Meeting of the American Epilepsy Society (AES 2023)	Dec. 02	GL
Xenon Pharmaceuticals Announces Pricing of Upsized $300.0 Million Public Offering	Nov. 29	GL
Xenon Pharmaceuticals Announces Proposed Public Offering	Nov. 29	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Xenon Pharmaceuticals Inc.

Equities

XENE

CA98420N1050

Press Releases

Filters